CAM
BIIB icon

Close Asset Management’s Biogen BIIB Stock Holding History

Close Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-24
Closed -$8K – 220
2017
Q4 		$8K Sell
24
-750
-97% -$241K ﹤0.01% 191
2017
Q3 		$242K Hold
774
– – 0.02% 82
2017
Q2 		$210K Hold
774
– – 0.02% 84
2017
Q1 		$212K Buy
+774
New +$219K 0.02% 85

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Close Asset Management's BIIB Position: Q1 2018 in Review

Close Asset Management sold out of Biogen (BIIB) in Q1 2018, closing a stake of 24 shares — an estimated $8K sold.

Close Asset Management first reported a position in BIIB in Q1 2017 and held it in 4 quarters. The position peaked at $242K in Q3 2017. 1,103 funds tracked by Wall St. Rank hold BIIB as of Q1 2018.

  • Close Asset Management reported no remaining Biogen position as of Q1 2018 after selling out during the quarter.
  • Close Asset Management sold 24 Biogen shares in Q1 2018, an estimated $8K.
  • Close Asset Management first reported a position in Biogen in Q1 2017 and held it in 4 quarters.
  • Close Asset Management's Biogen position peaked at $242K in Q3 2017.
  • 1,103 funds tracked by Wall St. Rank held Biogen as of Q1 2018.

Based on Close Asset Management's 13F filing for Q1 2018, filed 11 May 2018.